Human Protein FAM132A(FAM132A) ELISA kit

What it means: Target is the analyte this ELISA kit is designed to measure. The target shown here is FAM132A.

How to interpret here: Treat FAM132A as the “what you will quantify” in your samples. This listing shows species as Homo sapiens (Human)—species matching helps avoid under-recovery due to sequence differences. The assay type Sandwich ELISA (quantitative) affects curve behavior and interpretation (competitive vs sandwich). Plan dilutions so results fall within 31.25 pg/mL-2000 pg/mL. If you expect low abundance, compare expected baseline levels to the sensitivity (7.8 pg/mL). Choose this when the biology matches your study and the kit’s species/matrix/range fit your samples; consider another kit if you need validated performance in a different species/matrix or a different working range.

Targets are often used as biomarkers for pathway activity, disease models, or treatment response. Practical success depends on matching species/matrix and keeping readings within the standard curve.

Why it matters for buying:

• Correct biomarker match: Confirms you are measuring the intended analyte (related family members or isoforms can lead to misinterpretation if specificity matters).
• Species alignment: Species-matched kits (here Homo sapiens (Human)) reduce weak binding and inaccurate quantification.
• Matrix fit: Listed sample types (serum, plasma, cell culture supernates, tissue homogenates, cell lysates) indicate where the kit is expected to perform; unlisted matrices typically require extra validation.
• Throughput planning: Assay time (1-5h) affects batching and staffing, especially for larger cohorts.

How it impacts your workflow:

• Dilution series first: Run serial dilutions to land in the linear region and avoid saturation/below-range noise.
• Controls: Include blank, standards, and (when possible) a matrix-matched positive control; replicate low-level samples.
• Matrix validation: Use spike-recovery and dilution linearity (parallelism) before committing to a full study.

What to watch out for:

• Cross-reactivity and isoforms: If specificity is critical, check datasheet cross-reactivity notes and consider an orthogonal method.
• Sample handling: Keep samples cold, minimize freeze–thaw cycles, and follow recommended diluents to protect analyte stability.
• Near-limit calls: Close to 7.8 pg/mL, small background shifts can change detectability—tight technique and replicates matter.

What it means: Species indicates which organism the kit is validated/optimized to detect. The species shown here is Homo sapiens (Human).

How to interpret here: Use Homo sapiens (Human) as a primary compatibility gate. This kit is intended to measure FAM132A in Homo sapiens (Human) samples. Combine species with sample type (serum, plasma, cell culture supernates, tissue homogenates, cell lysates) to choose appropriate matrices and controls. Choose this when your study organism matches; validate carefully if you must use another species (spike recovery + parallelism) because sequence differences can reduce binding.

Species mismatch is a common cause of low signal or under-recovery in ELISA because antibody binding can change with protein sequence differences.

Why it matters for buying:

• Risk reduction: Species mismatch can cause false negatives or compressed standard curves.
• Comparability: Avoid comparing absolute concentrations across species unless you validated equivalent recovery in each species.
• Format interaction: With assay type Sandwich ELISA (quantitative), species mismatch can affect both capture and detection steps.

How it impacts your workflow:

• Matrix-matched controls: Keep species/matrix consistent across groups and runs to reduce confounding.
• Cross-species pilot: If using another species, test spike recovery and dilution linearity before scaling up.
• Interpretation discipline: Treat cross-species use as “needs validation,” not plug-and-play.

What to watch out for:

• Serum vs plasma differences: Anticoagulants (EDTA/heparin) can shift background; keep matrix consistent within a study.
• Low-level targets: Species/matrix mismatch can push borderline signals below detectability—use replicates and careful washing.

What it means: Sample Type(s) lists the matrices this kit is intended/commonly used for. The sample types shown are serum, plasma, cell culture supernates, tissue homogenates, cell lysates.

How to interpret here: Treat serum, plasma, cell culture supernates, tissue homogenates, cell lysates as your best hint for where this kit is expected to behave predictably. Pair it with species Homo sapiens (Human) to select matrix- and species-matched controls. Plan dilutions so results land within 31.25 pg/mL-2000 pg/mL. If expected levels are near 7.8 pg/mL, matrix background becomes a key limiter—pilot testing is strongly recommended. Choose this if your matrix matches (or you can validate a new matrix); consider another kit if you need validated performance in a different matrix with minimal development work.

Matrix effects are one of the biggest drivers of ELISA success. Background proteins, salts, lipids, and anticoagulants can change recovery and raise non-specific signal.

Why it matters for buying:

• Compatibility check: Unlisted matrices often require additional optimization and validation.
• Cost of failure: Matrix interference can force repeats; validated matrices save time and scarce samples.

How it impacts your workflow:

• Prep/clarify: Centrifuge to remove debris; consistent lysis/homogenization improves repeatability.
• Dilution series: Start with serial dilutions to reduce interference and identify the linear region.
• Validation checklist: Run spike recovery and parallelism (dilution linearity) before full cohorts.

What to watch out for:

• Hemolysis/lipemia: Can raise background and hide true signal.
• Protease activity: Some targets degrade quickly—keep samples cold and use inhibitors where appropriate.

What it means: Assay Type describes how the ELISA generates signal and how the standard curve should be interpreted. The assay type shown is Sandwich ELISA (quantitative).

How to interpret here: Use Sandwich ELISA (quantitative) to anticipate curve behavior and workflow strictness. This kit measures FAM132A. With matrices like serum, plasma, cell culture supernates, tissue homogenates, cell lysates, consistent prep and washing are key to control background. The assay time (1-5h) helps plan batching and staffing. Choose this if the format matches your analyte and interpretation needs; consider another format if you need a validated sandwich design or different curve behavior.

Assay format drives specificity, dynamic range, and tolerance to matrix interference. It also determines which controls are most informative for QC.

Why it matters for buying:

• Interpretation safety: Format knowledge prevents misreading the curve and calling wrong concentrations.
• Fit for analyte: Format selection impacts sensitivity and robustness in real samples.

How it impacts your workflow:

• Timing and washing: Follow recommended wash counts/soak times; keep incubation timing consistent to reduce CV.
• Stay on the curve: Use dilution series to avoid saturation and below-range noise.
• QC controls: Use blanks, standards, and matrix controls; verify curve shape before interpreting samples.

What to watch out for:

• Edge effects: Plate temperature gradients can shift signal; seal plates and equilibrate reagents.
• Matrix-driven drift: Different anticoagulants/lysis buffers can change background; validate when you change matrices.

What it means: Sensitivity is the lowest concentration the assay can reliably distinguish from background under recommended conditions. The sensitivity shown here is 7.8 pg/mL.

How to interpret here: Use 7.8 pg/mL as a feasibility check. If you expect baseline FAM132A levels near this value, plan a pilot run and replicates. Reliable quantification is best when results fall within 31.25 pg/mL-2000 pg/mL. In matrices like serum, plasma, cell culture supernates, tissue homogenates, cell lysates, background can reduce practical sensitivity—validate matrix effects (spike recovery + parallelism). Choose this if expected concentrations are comfortably above the sensitivity; consider a more sensitive kit if your baseline is near the limit or your matrix is challenging.

Sensitivity is related to, but not identical to, practical detection in every matrix. Real samples can raise background and effectively worsen the limit.

Why it matters for buying:

• Low-abundance feasibility: Helps you judge whether the kit can detect expected baseline levels.
• Risk/time planning: Near-limit work often requires extra validation, replicates, and careful technique—factor this into timelines and sample needs.

How it impacts your workflow:

• Pilot near expected range: Run dilution series to see where samples land on the curve.
• Background control: Clean pipetting, consistent washing, and avoiding plate drying preserve low-level detection.
• QC validation: Use spike recovery and parallelism, especially for serum/plasma and lysates.

What to watch out for:

• Hemolysis/lipemia: Can raise background and hide low signals.
• Inconsistent timing: Small incubation differences matter more at low concentrations.

What it means: Detection Range is the concentration interval where the assay is intended to quantify reliably. The detection range shown here is 31.25 pg/mL-2000 pg/mL.

How to interpret here: Use 31.25 pg/mL-2000 pg/mL to plan sample dilution and avoid re-runs. Sensitivity (7.8 pg/mL) indicates how low you can detect, while the range indicates where quantification is reliable. In matrices like serum, plasma, cell culture supernates, tissue homogenates, cell lysates, dilution helps reduce matrix effects and keep readings in-range. Choose this if your expected concentrations can be brought into this range with reasonable dilutions; consider a different range if your samples are consistently far above or below this window.

Staying within the working range improves accuracy and reduces the chance of saturation (too high) or unstable readings (too low).

Why it matters for buying:

• Quantitative reliability: Results are most dependable when readings fall within the stated range.
• Dilution strategy: Guides how much to dilute (or concentrate) samples before running.
• Reduced repeats: Matching expected levels to range lowers the risk of repeat testing due to out-of-range data.

How it impacts your workflow:

• Pre-test: Run a small pilot or dilution series to bracket expected concentrations.
• Re-dilute when needed: If saturated, dilute further; if below curve, reduce dilution or choose a more sensitive kit.
• Consistency: Keep diluent, timing, and wash technique consistent to preserve curve shape.

What to watch out for:

• Non-linear edges: Lowest/highest curve points are often less stable; aim for mid-curve when possible.
• Matrix shifts: Different matrices can shift apparent concentrations—validate with spike recovery/parallelism.

What it means: Assay Time is the approximate hands-on + incubation time needed to complete the assay workflow under recommended conditions. The assay time shown here is 1-5h.

How to interpret here: Use 1-5h to plan throughput and scheduling. With matrices like serum, plasma, cell culture supernates, tissue homogenates, cell lysates, allocate time for sample prep/clarification and keep incubations consistent. In a Sandwich ELISA (quantitative) format, timing consistency helps keep the standard curve stable run-to-run. Choose this if the runtime fits your lab schedule and sample stability window; consider alternatives if you need faster turnaround or must process many plates in parallel.

Assay time affects reproducibility: consistent incubations and washes reduce variability, especially across operators or multiple plates.

Why it matters for buying:

• Throughput planning: Determines how many plates you can run per day and staffing needs.
• Sample stability: Longer workflows may require colder handling and careful batching for unstable analytes.
• Reproducibility: Tight timing control reduces plate-to-plate variability.

How it impacts your workflow:

• Batch strategy: Stagger plate starts so wash/incubation timing stays consistent.
• Equipment readiness: Plan for plate washer (or manual wash), timers, and temperature control.
• Documentation: Record step timing to troubleshoot drift across runs.

What to watch out for:

• Rushing washes: Short/inconsistent washes increase background.
• Plate drying: Drying between steps can elevate background—keep workflow continuous.
• Operator variation: Standardize timing and mixing to reduce variability.